Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke-Reference-Cited by-同舟云学术

Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke

Published:2019-06-01 Issue:6 Volume:26 Page:528-537
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Lin Jing¹,Han Zhao²,Yi Xingyang³,Luo Hua⁴,Zhou Qiang¹,Zhou Ju³

Affiliation:

1. Department of Neurology, Third Affiliated Hospital of Wenzhou Medical University

2. Department of Neurology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

3. Department of Neurology, People's Hospital of Deyang City

4. Department of Neurology, the Affiliated Hospital of Southwest Medical University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/26/6/26_46136/_pdf

Reference45 articles.

1. 1) Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA: Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014; 45: 3754-3832

2. 2) Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lance, 2009; 373: 1849-1860

3. 3) Bartolucci AA, Tendera M, Howard G: Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol, 2011; 107: 1796-1801

4. 4) Sanossian N, Saver JL, Rajajee V, Selco SL, Kim D, Razinia T, Ovbiagele B: Premorbid antiplatelet use and ischemic stroke outcomes. Neurology, 2006; 66: 319-323

5. 5) Jung JM, Choi J, Eun MY, Seo WK, Cho KH, Yu S, Oh K, Hong S, Park KY: Prestroke antiplatelet agents in firstever ischemic stroke: clinical effects. Neurology, 2015; 84: 1080-1089

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of preceding antiplatelet agents on severity of ischemic stroke in patients with a history of stroke;Journal of the Neurological Sciences;2024-01

2. Early antithrombotic therapy in patients with postinterventional cerebral hyperdensity reduces early neurological deterioration after mechanical thrombectomy;BMC Neurology;2023-12-15

3. Ischaemic stroke despite antiplatelet therapy: Causes and outcomes;European Stroke Journal;2023-05-24

4. A Bibliometric Analysis of Cardioembolic Stroke From 2012 to 2022;Current Problems in Cardiology;2023-03

5. Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarction;Journal of Neurology, Neurosurgery & Psychiatry;2022-04-26